(3R)-3-(1,3-DIHYDRO-1-OXO-5-(4-((1-(4-((1R,2S)-1,2,3,4-TETRAHYDRO-6-HYDROXY-2-PHENYL-1-NAPHTHALENYL)PHENYL)-4-PIPERIDINYL)METHYL)-1-PIPERAZINYL)-2H-ISOINDOL-2-YL)-2,6-PIPERIDINEDIONE
UNII TQF7D54NBP
Substance Identification & Data
This profile provides standardized clinical and technical data for (3r)-3-(1,3-dihydro-1-oxo-5-(4-((1-(4-((1r,2s)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl)phenyl)-4-piperidinyl)methyl)-1-piperazinyl)-2h-isoindol-2-yl)-2,6-piperidinedione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TQF7D54NBP.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2229711-70-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C45H49N5O4 TZZDVPMABRWKIZ-YOXBLASKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3r)-3-(1,3-dihydro-1-oxo-5-(4-((1-(4-((1r,2s)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl)phenyl)-4-piperidinyl)methyl)-1-piperazinyl)-2h-isoindol-2-yl)-2,6-piperidinedione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.